Clinigen announces acquisition of Cardioxane from Novartis

[News]

Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.

More... (http://www.news-medical.net/news/20130326/Clinigen-announces-acquisition-of-Cardioxane-from-Novartis.aspx)